Cancer Institute A national cancer institute
designated cancer center

Melanoma Clinics

Doctors at the Pigmented Lesion and Cutaneous Melanoma Clinic follow patients at increased risk of melanoma

The Stanford Pigmented Lesion and Melanoma Program is structured with parallel melanoma clinics occurring weekly on Wednesday mornings (8 AM to noon) at the Stanford Cancer Center, including the:

Through these simultaneously-run melanoma clinics, a Stanford melanoma “tumor board” occurs every week, with frequent communication among specialists on a daily basis to provide a multidisciplinary approach for melanoma patients of all disease stages.  Additional surgery and medical oncology clinics are available throughout the week. 

Pigmented Lesion and Melanoma Clinic

Cutaneous melanoma patients and individuals with atypical nevi (moles) are primarily managed in the Pigmented Lesion and Melanoma Clinic. This clinic was developed to follow patients at increased risk of melanoma based on mole pattern and family history as well as to provide initial evaluation and ongoing surveillance for patients with cutaneous (skin) and more advanced melanoma.

Patients with Atypical Mole Syndrome are described as having over 50 to 100 moles with generally 5 or more showing clinical atypia (variation in color or irregular, asymmetric borders, and/or size greater than 8mm diameter). Affected individuals are estimated to have a 5-50-fold increased risk of melanoma depending on family history of melanoma.

The Stanford Pigmented Lesion and Melanoma Clinic employs total body mole mapping through DigitalDerm™ to assist in the early detection of severely atypical moles and cutaneous melanoma. Most skin melanomas do not arise from a pre-existing mole, which adds to the advantage of total body photography for assessing new or changing pigmented lesions. Mole mapping is generally recommended for appropriate patients on a one-time basis, and individuals are encouraged to use the photos to assist with regular skin self-examinations. Stanford Dermatology is the sole provider of Digital Derm total body mole mapping in the San Francisco Bay Area.  See Stanford Dermatology for more information on DigitalDerm total body mole mapping.

Stanford is a participant in the National Cancer Institute/University of Arizona Phase I/II Cancer Chemoprevention Consortium, designed to prevent melanoma and other skin cancers in high-risk individuals at the outset. 

For patient referral, please contact the Stanford Melanoma Program new patient coordinator at (650) 725-9369 (referring physicians) or (650) 498-6000 (new patients).

Melanoma Surgery and Medical Oncology Clinics

Stanford surgeons (dermatology, head and neck, general surgery/surgical oncology) perform surgery for all stages of melanoma. Patients with metastatic melanoma (lymph node metastasis and disseminated disease) are generally managed by Stanford melanoma oncologists, including potential entry into clinical trials open at Stanford. However, the simultaneously occurring dermatology, surgery, and oncology clinics allow for multi-specialty input into the care of complex patients on an ongoing basis.

Stanford Medicine Resources:

Footer Links: